David Wahlberg, Wisconsin State Journal October 18, 2018 With flu season approaching, health officials say people should get flu shots by the end of October, yet acknowledge that the annual… read more →
—Influenza challenge virus genetically drifted by six years from vaccine strain — MADISON, Wis., October 15, 2018—FluGen, Inc. announced today that all subjects have completed dosing in a first-of-its-kind clinical… read more →
NIAID-Supported Phase 1 Trial of Potential Broadly Protective Vaccine September 17, 2018 An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy… read more →
FLUGEN BEGINS ENROLLMENT OF CLINICAL TRIAL OF NOVEL INVESTIGATIONAL INFLUENZA VACCINE AGAINST MULTI-SEASON MISMATCHED STRAINS —Investigational vaccine designed to generate broad and durable immune protection over multiple influenza seasons— —Subjects… read more →